The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K.
Fujii A, et al. Among authors: iwata m.
Cancer Sci. 2021 Apr;112(4):1655-1668. doi: 10.1111/cas.14858. Epub 2021 Mar 5.
Cancer Sci. 2021.
PMID: 33605496
Free PMC article.